To Applicants:

The University of Washington is actively monitoring the impact of COVID-19 in our region and across the US. We are following guidance from local health departments and the Centers for Disease Control and Prevention (CDC), on preventing the spread of COVID-19.  

Since the main defense against the novel coronavirus at this time is containment,  the UW Dept of Gynecologic Oncology will conduct virtual interviews for 2021 fellowship candidates to reduce the need to travel.   We are currently planning to maintain the timeline of applications due April 15, 2020 and offering invitations May 6, 2020 for June 5, 2020 and Jun 19, 2020 interview dates.   However, these are subject to change as the situation evolves.   

Updates will be communicated through our website, so please check our webpage regularly for any new information.  Thank you for your understanding and patience during this challenging time. 

SGO and our institution recognize the impact of the COVID-19 pandemic on our professional lives. In an effort to provide sufficient time and attention to your application, the due date for your application is April 15, 2020. Invitations to interview will be sent on May 6, 2020.

The gynecologic oncology fellowship at the University of Washington (UW) is a four-year program accepting one applicant per year for a maximum of four fellows at any given time.

The program has been developed to train gynecologic oncologists who will be leaders in patient care, research, surgical expertise, innovative cancer therapies, and education. We intend to accomplish this by training fellows in the comprehensive management of gynecologic malignancies and research. We believe that strong mentorship is the best way to assure success of our fellows and therefore we will pair them with both research and clinical mentors.

The fellowship is based primarily at the University of Washington Medical Center (UWMC) and Seattle Cancer Care Alliance (SCCA), and includes rotations at Swedish Medical Center (SMC). UWMC is a 450-bed hospital providing tertiary care for the Pacific Northwest region. It is a major clinical resource for high-risk obstetrics, neonatology, gynecologic oncology, urogynecology, assisted reproductive endocrinology, infectious diseases, genetics, and breast cancer.

SCCA is an alliance between UWMC, Fred Hutchinson Cancer Research Center (FHCRC), and Children's Hospital and Regional Medical Center (CHRMC). The SCCA provides comprehensive cancer care for the Northwest region. FHCRC and UWMC are designated as an NCI Comprehensive Cancer Center. As part of this consortium, there is a dedicated gynecologic cancer research program.

The division of gynecologic oncology at UW includes ten board-certified gynecologic oncologists. Each faculty member is active in clinical and/or laboratory research. While the surgical and clinical experience is exceptional, this program also provides an excellent opportunity for epidemiologic or basic science research. FHCRC has developed a gynecologic cancer research program (GCRP) that brings together researchers with common interests in gynecologic malignancies, provides infrastructure for data collection, tissue banking, and funds for pilot projects. FHCRC, in collaboration with UW and SMC currently has an NIH ovarian cancer SPORE grant, one of only five in the U.S., and is actively conducting research projects in early detection, biomarker development, chemoresistance, and modeling for prediction of cancer. UW is one of the lead sites for HPV vaccine research and cancer genetics. FHCRC actively studies the epidemiology of gynecologic malignancies. For fellows with interests in any of these areas, we have identified mentors who have agreed to participate in the research training.

The UW provides office space, computers, and secretarial, library, medical illustration and graphics support for the fellows.

Program Revisions

On January 1, 2020, Northwest Hospital in Seattle was formally incorporated as the second campus of the University of Washington Medical Center. This has prompted our fellowship to make program revisions. Beginning on July 1, 2021, the third and fourth year fellows will have clinical rotations at the Montlake (main) and Northwest Campuses at the University of Washington. Fellows currently applying for the upcoming match in 2021 will have their clinical experience entirely at the University of Washington.

2020 Application Information

Applications will be accepted through the Electronic Residency Application System (ERAS) website: https://www.aamc.org/students/eras

NOTE: Applicants must be USA citizens or permanent residents (green card) and must have completed an ACGME accredited residency in obstetrics and gynecology by the fellowship start date. Due to the nature of fellowship funding, applications from H1B and J1 Visa holders cannot be accepted.

We are following the Society of Gynecologic Oncology Common Application Dates (https://www.sgo.org/education/fellowship-applicants/). 

2020 Application Deadline: 

Wednesday, April 15, 2020

2020 Fellowship Interview Dates: 

Friday, June 5, and Friday, June 19, 2020

 

Applications must include:

  • Three letters of recommendation
  • Letter of good standing from program director
  • Current curriculum vitae
  • Personal statement
  • Official transcript from all medical schools attended
  • MSPE
  • USMLE transcript, including all attempts
  • CREOG scores
  • Copy of medical school diploma
  • Recent photograph
 
For further information, please contact:
Gynecologic Oncology Fellowship Administrator
Department of Obstetrics and Gynecology, Box 356460
University of Washington School of Medicine
Seattle, WA 98195-6460
Phone: 206-543-3891
Fax: 206-543-3915
 
At all times fellows will adhere to an 80-hour work week.